Radiation Oncology near Tampa, FL

Care Philosophy: We work as a team to make sure that every patient receives the highest quality, most effective treatment available today. That's especially true for prostate cancer patients, where there are so many options. For us, treating prostate cancer is not only about curing the disease, but assuring each patient's long term quality of life. Toward that end, I establish open communications with my patients, for their ease of access and peace of mind from diagnosis through recovery.

Biography: Dr. Richard Tuli, MD is a Radiation Oncology Specialist who practices in Tampa, FL. He is 50 years old. Dr. Richard Tuli, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Biography: Brian Collins, MD, is the Clinical Director of the Department of Radiation Oncology at MedStar Georgetown University Hospital and an Assistant Professor at Georgetown University School of Medicine. Dr. Collins joined the staff in 2001 after completing his residency at MedStar Georgetown. Previously, he received his medical degree from SUNY-Stony Brook, and fulfilled his internship at St. Vincent's Hospital and Medical Center in New York City. Board certified in radiation oncology, Dr. Collins has a particular interest in treating central nervous system cancers, lung cancers and breast cancers. He is a recognized specialist in CyberKnife radiotherapy technology. A frequent contributor to scientific journals, books and publications, he also sits on several editorial review boards. Dr. Collins is a Fellow in the American College of Chest Physicians (ACCP) and a member of numerous related organizations. Professional Memerships American College of Chest Physicians (ACCP), Fellow Radiological Society of North America (RSNA) American Society for Radiation Oncology (ASTRO) American Society of Clinical Oncology (ASCO) Publications Lischalk JW, Woo SM, Kataria S, Aghdam N, Paydar I, Repka MC, Anderson ED, Collins BT.Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol. 2016;5(4):379-387. doi: 10.1007/s13566-016-0273-4.PMID:28018523 Obayomi-Davies O, Kole TP, Oppong B, Rudra S, Makariou EV, Campbell LD, Anjum HM, Collins SP, Unger K, Willey S, Tousimis E, Collins BT. Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform. Front Oncol. 2016 May 23;6:129. doi: 10.3389/fonc.2016.00129.PMID:27242967 Kress MA, Oermann E, Ewend MG, Hoffman RB, Chaudhry H, Collins B. Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure. Radiat Oncol. 2013 Mar 19;8:64. doi: 10.1186/1748-717X-8-64.PMID:23510318 Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT. Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach. Front Oncol. 2012 Apr 26;2:39. doi: 10.3389/fonc.2012.00039. PMID:22645718 Oermann E, Collins BT, Erickson KT, Yu X, Lei S, Suy S, Hanscom HN, Kim J, Park HU, Eldabh A, Kalhorn C, McGrail K, Subramaniam D, Jean WC, Collins SP. CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. J Hematol Oncol. 2010 Jun 9;3:22. doi: 10.1186/1756-8722-3-22.PMID:20534128

Care Philosophy: To help people achieve health for life.

Biography: Dr. Randy Kahn is a Board Certified Radiation Oncologist on staff at HCA Florida South Shore Hospital. He attended medical school at New York University School of Medicine and completed his residency at University of Miami and New York University.

Care Philosophy: Dr. Steel served three years in the United States Air Force as Chief of_x000D_ Radiation Oncology at Kessler Medical Center in Biloxi, Mississippi._x000D_ _x000D_ Dr. Steel has performed over 4,000 prostate seed implant procedures._x000D_ Additionally, Dr. Steel has extensive training in all areas of cancer_x000D_ treatment including lung, head and neck, breast, skin and GI malignancies.

Biography: Dr. Craig E. Grossman is a radiation oncologist at Tampa General Hospital (TGH). Before coming to TGH, Dr. Grossman accumulated an extensive range of professional and academic experiences. Most recently, he served as an Assistant Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York, and and trained radiation therapists and dosimetrists as a Clinical Assistant Professor in the School of Health Technology and Management at Stony Brook University in Stony Brook, New York.Dr. Grossman has shared his expertise on a variety of radiation oncology topics through lectures at international meetings, hospitals and universities, and in the community. He has also contributed to the development of innovative radiation treatments, as well as published national guidelines related to genitourinary cancer (i.e. prostate, bladder, testicular) and gynecology cancer (i.e. endometrial, cervix, vagina, vulva) management. He is an expert in the treatment of prostate cancer with brachytherapy and stereotactic body radiotherapy (SBRT) among other treatment modalities, as well as treating women with various radiation techniques for their gynecologic cancer. Dr. Grossman has both clinical and research interests in sexual medicine, minimizing radiation-related side effects, and new technologies to treat cancer to improve cure rates.

Care Philosophy: Dr Sarah Hoffe is the Section Head of GI Radiation Oncology at Moffitt Cancer Center and joined the faculty in 2006. She is a Senior Member at Moffitt and Professor in the University Of South Florida Morsani College Of Medicine's Department of Oncologic Sciences. Dr Hoffe's research and clinical interests include cancers of the esophagus, stomach, liver, pancreas, bile duct, rectum, colon, anus, as well as neuroendocrine cancers.